Scarica l'app Stockscreener
4.32
3.60%
0.15
Pre-mercato:
4.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Orasure Technologies Inc Borsa (OSUR) Ultime notizie
OraSure receives FDA clearance for home urine collection kit for STIs - Lehigh Valley Business
Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now? - Yahoo Finance
FDA Clears Home Urine Collection Kit for STI Testing - Conexiant
OraSure Wins FDA Clearance for At-Home STI Collection - TipRanks
OraSure secures FDA clearance for product seen as key to future growth - WFMZ.com
OraSure stock jumps on FDA clearance for at-home STI kit - Investing.com
OraSure stock jumps on FDA clearance for at-home STI kit By Investing.com - Investing.com South Africa
OraSure Technologies (NASDAQ: OSUR) wins FDA clearance for Colli-Pee Dx at-home urine collection kit - Stock Titan
OraSure gets FDA nod for at-home STI urine collection kit By Investing.com - Investing.com Australia
OraSure gets FDA nod for at-home STI urine collection kit - Investing.com India
OraSure receives FDA clearance for at-home STI urine collection kit - StreetInsider
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections - The Manila Times
FDA clears at-home urine kit that lets labs test for 4 STIs by mail - Stock Titan
OraSure Technologies (OSUR) Slips 3.1% as Stock Tests Key Support LevelOvernight Profile - newsline.com
Is Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now? - Yahoo Finance
OraSure Technologies (OSUR) director receives 46,106-share restricted stock grant - Stock Titan
OraSure (OSUR) director Nancy Gagliano receives 46,106-share stock award - Stock Titan
OraSure Technologies (OSUR) director receives 46,106-share stock grant - Stock Titan
OraSure (OSUR) director John P. Kenny granted 46,106 restricted shares - Stock Titan
Director at OraSure (NASDAQ: OSUR) receives 46,106 restricted shares - Stock Titan
Earnings call transcript: OraSure Technologies Q1 2026 misses earnings and revenue forecasts - Investing.com UK
OraSure Technologies Investors Approve Expanded Stock Plan, Governance Changes - The Globe and Mail
OraSure Technologies (NASDAQ: OSUR) OKs more equity awards and board declassification - Stock Titan
OraSure Technologies Hits New 52-Week High of $4.33, Marking Significant Growth - Markets Mojo
OSUR Q1 2026 Earnings: EPS Miss by 69% Signals Operational HeadwindsFree Cash Flow Trends - newsline.com
OraSure Technologies, Inc.Common Stock (NQ: OSUR - FinancialContent
OraSure Technologies (OSUR) Gains 6%: Testing Resistance as Momentum BuildsEase of Movement - The Legal Advocate
OraSure Technologies Hits New 52-Week High at $4.00 - Markets Mojo
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com
OraSure Technologies Hits New 52-Week High at $4.12 - MarketsMojo
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - MarketBeat
OraSure Technologies (OSUR) Gains 3.68% as Stock Approaches Key Resistance LevelNHNL Divergence - The Legal Advocate
OraSure Technologies (OSUR) price target increased by 25.00% to 5.10 - MSN
Insiders Buying OraSure Technologies Might Wish They Invested More, Stock Gains 28% - Moomoo
OraSure Technologies (OSUR) Surges 9%: Key Levels to Watch After Strong MoveBearish Pattern Stocks - The Legal Advocate
OraSure Technologies Inc. (OSUR) Q1 2026 Earnings: Wider-than-Expected Loss Raises Concerns Despite Stock SurgeInvestor Earnings Call - The Legal Advocate
OraSure Technologies (OSUR) Surges 7% as Shares Approach Resistance at $3.45Institutional Volume - newsline.com
Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
OraSure Technologies Independent Director Acquires 195% More Stock - Yahoo Finance
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Insider Buying: Steven Boyd Acquires 75,000 Shares of OraSure Te - GuruFocus
OraSure director Steven Boyd purchases $224,750 in stock By Investing.com - Investing.com India
OraSure director Steven Boyd purchases $224,750 in stock - Investing.com
[Form 3] ORASURE TECHNOLOGIES INC Initial Statement of Beneficial Ownership - Stock Titan
Director at OraSure (NASDAQ: OSUR) awarded 33,661 restricted shares - Stock Titan
1.68%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):